NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs031230672

Registered date:04/03/2024

Single-arm clinical trial of MOVICOL as a drug for preparation in children colonoscopy

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPreparation in children colonoscopy
Date of first enrollment04/03/2024
Target sample size36
Countries of recruitment
Study typeInterventional
Intervention(s)MOVICOL should be taken as two packets (120mL) per dose for 2-14 years old children and as three packets (180mL) per dose for over 12 years old, by dissolving one packet in 60 mL of water, tea, juice, or other solution. The timing and number of doses should be three times in total: in the afternoon and evening on the day before the colonoscopy, and in the morning on the day of the colonoscopy, and each dose should be taken within 2 hours.

Outcome(s)

Primary OutcomeBowe cleansing efficacy at the time of endoscopy (percentage of patients with Boston Bowel Preparation Scale (BBPS) >= 6).
Secondary OutcomeCecal intubation rate. Acceptability Tolerability(questionnaire). Frequency and incidence of adverse events .

Key inclusion & exclusion criteria

Age minimum>= 2age old
Age maximum<= 15age old
GenderBoth
Include criteria1.2 -15 years old at the time of obtaining consent. 2.Written informed consent obtained from patient and/or guardians.
Exclude criteria1.Patients who have been on fasting for a long period of time and do not need pretreatment. 2.Patients requiring urgent colonoscopy. 3.Patients who are suspected of having bowel obstruction or ileus /intestinal perforation, toxic megacolon, acute abdomen, or stenotic lesions, and who are not eligible for regular preparation. 4.Patients with serious complications. 5.Patients with severe mental disorders or developmental disorders who have difficulty communicating. 6.Patients with a history of severe hypersensitivity to MOVICOL components. 7.Patients who are judged as ineligible for registration by attending doctors.

Related Information

Contact

Public contact
Name Yoshifumi Ito
Address 1-5-45, Yushima, Bunkyo-ku, Tokyo Tokyo Japan 113-8519
Telephone +81-3-5803-5261
E-mail ito.srg2@tmd.ac.jp
Affiliation Tokyo Medical and Dental University Hospital
Scientific contact
Name Kentaro Okamoto
Address 1-5-45, Yushima, Bunkyo-ku, Tokyo Tokyo Japan 113-8519
Telephone +81-3-5803-5261
E-mail okasrg2@tmd.ac.jp
Affiliation Tokyo Medical and Dental University Hospital